Now:Suggest a Topic: Difference between revisions
(Created page with "==Potential Topics== Please insert here suggestions on controversial issues in EM for us to pilot. The ideal (at least initial) topics are ones in which there is true debate ...") |
|||
| Line 2: | Line 2: | ||
Please insert here suggestions on controversial issues in EM for us to pilot. The ideal (at least initial) topics are ones in which there is true debate in the literature, there currently lacks a clear management guideline, and in which doctors have to actually make a decision in real life. The evidence may be unclear, but that does not stop us from having to choose an option. Theoretical debates are not of interest. Some of my initial thoughts on potential topics are: | Please insert here suggestions on controversial issues in EM for us to pilot. The ideal (at least initial) topics are ones in which there is true debate in the literature, there currently lacks a clear management guideline, and in which doctors have to actually make a decision in real life. The evidence may be unclear, but that does not stop us from having to choose an option. Theoretical debates are not of interest. Some of my initial thoughts on potential topics are: | ||
*Octreotide for upper GI bleed | |||
*Metoprolol vs. diltiazem in for A. fib with RVR | |||
*Kayexelate for patients with hyperkalemia in renal failure | |||
*tPA use in acute CVA | |||
*tPA in PE subsets | |||
*Discharge of Newly Diagnosed Pulmonary Embolism From the ED | |||
*CTA vs V/Q in pregnant pts needing PE r/o | |||
Revision as of 17:30, 15 May 2014
Potential Topics
Please insert here suggestions on controversial issues in EM for us to pilot. The ideal (at least initial) topics are ones in which there is true debate in the literature, there currently lacks a clear management guideline, and in which doctors have to actually make a decision in real life. The evidence may be unclear, but that does not stop us from having to choose an option. Theoretical debates are not of interest. Some of my initial thoughts on potential topics are:
- Octreotide for upper GI bleed
- Metoprolol vs. diltiazem in for A. fib with RVR
- Kayexelate for patients with hyperkalemia in renal failure
- tPA use in acute CVA
- tPA in PE subsets
- Discharge of Newly Diagnosed Pulmonary Embolism From the ED
- CTA vs V/Q in pregnant pts needing PE r/o